Standout Papers
- Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome (2024)
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease (2020)
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study (2016)
- Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol (2022)
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials (2016)
Immediate Impact
11 from Science/Nature 76 standout
Citing Papers
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
Refining the impact of genetic evidence on clinical success
2024 StandoutNature
Works of Shuting Xia being referenced
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
2020 Standout
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Shuting Xia | 1452 | 1726 | 871 | 51 | 3.6k | |
| Toshio Nagai | 3005 | 1459 | 1590 | 97 | 5.4k | |
| Ryuichi Aikawa | 2629 | 875 | 1327 | 40 | 4.1k | |
| Micheline Duriez | 2342 | 1253 | 1420 | 58 | 5.6k | |
| Haruhiro Toko | 3486 | 1303 | 2306 | 71 | 5.9k | |
| John J. Lepore | 2387 | 830 | 1231 | 59 | 4.6k | |
| Satoshi Murasawa | 3571 | 1258 | 2293 | 46 | 6.0k | |
| Thomas N. Tulenko | 1435 | 1454 | 677 | 74 | 3.8k | |
| Paul D. Upton | 1805 | 697 | 1182 | 72 | 5.1k | |
| Mattia Albiero | 2793 | 763 | 630 | 85 | 5.6k | |
| S E Rittenhouse | 3322 | 476 | 799 | 54 | 5.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...